Delayed administration of carrier marrow can decrease competition on donor stem cells during engraftment and maintain radioprotection of the host

Experimental Hematology

Volumn 30, Issue 7, 2002, Pages 837-845

  Soper, Brian W ^a   Lessard, Mark D ^a   Jude, Craig D ^a   Schuldt, Adam J ^a   Barker, Jane E ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL CYCLE; CELL DIVISION; CELL POPULATION; CONTROLLED STUDY; DONOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION; RECIPIENT; STEM CELL; STROMA;

ANIMALS; BENZIMIDAZOLES; BONE MARROW TRANSPLANTATION; CELL DIVISION; CELL LINEAGE; DISEASE MODELS, ANIMAL; FLUORESCENT DYES; GLUCURONIDASE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MUCOPOLYSACCHARIDOSIS VII; RADIATION TOLERANCE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036321707     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00834-2     Document Type: Article

References (34)

1. Transplantation in relation to the treatment of inherited disease
2. Bone marrow transplants in genetic diseases
3. The mucopolysaccharidoses
4. Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency
5. Bone marrow transplantation. II. Use for aplastic anemia, hereditary diseases, and hemoglobinopathies
6. Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis
7. Murine mucopolysaccharidosis type VII. Characterization of a mouse with β-glucuronidase
8. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation
9. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates
10. Nonablative neonatal marrow transplantation attenuates functional and physical defects of β-glucuronidase deficiency
11. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII
12. Competitive repopulation: A new assay for long-term stem cell functional capacity
13. Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells
14. Primitive hemopoietic stem cells: Direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations
15. Purification and characterization of mouse hematopoietic stem cells
16. Countercurrent centrifugal elutriation (CCE) recovery profiles of hematopoietic stem cells in marrow from normal and 5-FU-treated mice
17. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells
18. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo
19. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species
20. β-glucuronidase binding to human fibroblast receptors
21. Murine mucopolysaccharidosis type VII: A model system for somatic gene therapy of the central nervous system
22. A genetically myeloablated MPS VII model detects the expansion and curative properties of as few as 100 enriched murine stem cells
23. Conditions controlling the proliferation of hematopoietic stem cells in vitro
24. Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine
25. Assignment of genes to regions of mouse chromosomes
26. Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division
27. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts
28. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts
29. Engraftment of bone marrow cells into normal unprepared hosts: Effects of 5-fluorouracil and cell cycle status
30. The biology of hematopoietic stem cells
31. The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells
32. Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome
33. Hematopoietic cell transplantation for mucopolysaccharidosis IIB (Hunter syndrome)
34. Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation